Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Centessa Pharmaceuticals, a wholly owned subdisary of Eli Lilly and Company, is seeking a Senior Scientist to lead Safety Assessment with a focus on data auditing, regulatory SENDs, and cross-functional collaboration. This 100% remote role operates within the US, supporting early pipeline decision-making and governance processes.
The position emphasizes advanced data visualization, regulatory auditing, literature synthesis, and PDT leadership, requiring strong toxicology operations experience
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa’s OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.
__Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work in 2026.
We are seeking an analytically elite, strategically minded Senior Scientist to join our Safety Assessment team. This is a 100% non-laboratory position designed for a seasoned bioscientist or toxicology operations expert who thrives at the intersection of dataset auditing, mechanistic evaluation, and cross-functional project leadership.
As a Senior Scientist, you will serve as a vital scientific and strategic hub connecting Centessa’s internal toxicology leaders with Project Development Teams (PDTs) and adjacent disciplines (including DMPK, CMC, Regulatory, and Clinical Operations). You will own the analytical pipeline for incoming toxicology studies—spearheading the audit of regulatory SEND datasets, engineering data visualizations of complex toxicology endpoints, and authoring authoritative literature reviews. Your insights will directly shape investigative toxicology strategies, driving early pipeline decision‑making and securing project endorsements at internal governance committees.
Education: B.S. or M.S. degree in Toxicology, Pharmacology, Cellular/Molecular Biology, Bioinformatics, or a related life sciences discipline.
Experience Required:
Core Technical Competencies:
Leadership & Influence: Superb technical writing skills paired with a demonstrated ability to distill vast pools of complex data into clear arguments capable of convincing diverse, cross‑functional scientific leaders.
The annual base salary range for this position is $85,000 to $130,000. Individual compensation within this range will be determined based on a variety of factors, including qualifications, skills, relevant experience, job knowledge and location.
In addition to base pay, this role is eligible for a discretionary annual bonus. The Company also offers a comprehensive benefits package, which includes a 401(k) plan, company‑sponsored medical, dental, vision, and life insurance, generous paid time off, and a health and wellness program.
This role is remote and based in the US, with occasional travel.
Full-Time, Exempt
Centessa Pharmaceuticals, a wholly owned subdisary of Eli Lilly and Company believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion, or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. We will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
We will not assign referral rights for any unsolicited resumes from recruitment agencies.